| Code | Description | Claims | Beneficiaries | Total Paid |
| 99215 |
Prolong outpt/office vis |
25,275 |
21,797 |
$1.46M |
| 99205 |
Prolong outpt/office vis |
7,473 |
7,451 |
$631K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,487 |
7,495 |
$348K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,439 |
1,828 |
$93K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,205 |
2,078 |
$23K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,132 |
1,049 |
$21K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
688 |
646 |
$17K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
201 |
169 |
$2K |
| 81000 |
|
401 |
398 |
$543.24 |
| 81001 |
|
448 |
435 |
$400.87 |
| 81025 |
|
14 |
14 |
$38.81 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
20 |
20 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
36 |
33 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
25 |
25 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
22 |
22 |
$0.00 |
| 87492 |
|
12 |
12 |
$0.00 |
| 97597 |
|
13 |
13 |
$0.00 |